Your browser doesn't support javascript.
loading
Recurrent Wnt medulloblastoma treated with marrow-ablative chemotherapy and autologous hematopoietic progenitor cell rescue: a dual case report and review of the literature.
Harris, Micah K; Shatara, Margaret; Funk, Zachary; Stanek, Joseph; Boué, Daniel R; Jones, Jeremy; Finlay, Jonathan L; Abdelbaki, Mohamed S.
Affiliation
  • Harris MK; The Division of Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital and The Ohio State University, Columbus, OH, 43205, USA.
  • Shatara M; The Ohio State University College of Medicine, Columbus, OH, 43210, USA.
  • Funk Z; The Division of Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital and The Ohio State University, Columbus, OH, 43205, USA.
  • Stanek J; The Division of Pediatric Hematology and Oncology, Washington University School of Medicine, 1 Children's Pl, St. Louis, MO, 63011, USA.
  • Boué DR; The Division of Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital and The Ohio State University, Columbus, OH, 43205, USA.
  • Jones J; The Division of Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital and The Ohio State University, Columbus, OH, 43205, USA.
  • Finlay JL; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital and The Ohio State University, Columbus, Ohio, 43210, USA.
  • Abdelbaki MS; The Department of Radiology, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, 43205, USA.
Childs Nerv Syst ; 38(2): 465-472, 2022 02.
Article de En | MEDLINE | ID: mdl-33948723
ABSTRACT
Wnt-activated medulloblastoma (MB) confers an excellent prognosis. However, specific treatment strategies for patients with relapsed Wnt-MB are unknown. We report two patients with recurrent beta-catenin nucleopositive Wnt-MB successfully treated by incorporating marrow-ablative chemotherapy and autologous hematopoietic progenitor cell rescue (HDCx/AuHPCR). We also present a review of the literature for previously reported cases of relapsed Wnt-MB. We propose that patients with recurrent Wnt-MB may be treated using a multi-disciplinary approach that includes HDCx/AuHPCR with or without re-irradiation.
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du cerveau / Tumeurs du cervelet / Médulloblastome Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Childs Nerv Syst Sujet du journal: NEUROLOGIA / PEDIATRIA Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du cerveau / Tumeurs du cervelet / Médulloblastome Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Childs Nerv Syst Sujet du journal: NEUROLOGIA / PEDIATRIA Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique